ArticleCurrent oncology (Toronto, Ont.)2026
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer: Real-World Outcomes and Treatment Transition Patterns in a Chinese Cohort.
Yifei Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.